FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213528083> ?p ?o ?g. }

• W3213528083 endingPage "537" @default.
• W3213528083 startingPage "527" @default.
• W3213528083 abstract "Endoxifen is the most important active metabolite of tamoxifen. Several retrospective studies have suggested a minimal or threshold endoxifen systemic concentration of 14-16 nM is required for a lower recurrence rate. The aim of this study was to investigate the feasibility of reaching a predefined endoxifen level of ≥ 16 nM (5.97 ng/mL) over time using therapeutic drug monitoring (TDM).This prospective open-label intervention study enrolled patients who started treatment with a standard dose of tamoxifen 20 mg once daily for early breast cancer. An outpatient visit was combined with a TDM sample at 3, 4.5, and 6 months after initiation of the tamoxifen treatment. The tamoxifen dose was escalated to a maximum of 40 mg if patients had an endoxifen concentration < 16 nM. The primary endpoint of the study was the percentage of patients with an endoxifen level ≥ 16 nM at 6 months after the start of therapy compared with historical data, in other words, 80% of patients with endoxifen levels ≥ 16 nM with standard therapy.In total, 145 patients were included. After 6 months, 89% of the patients had endoxifen levels ≥ 16 nM, compared with a literature-based 80% of patients with endoxifen levels ≥ 16 nM at baseline (95% confidence interval 82-94; P = 0.007). In patients with an affected CYP2D6 allele, it was not always feasible to reach the predefined endoxifen level of ≥ 16 nM. No increase in tamoxifen-related adverse events was reported after dose escalation.This study demonstrated that it is feasible to increase the percentage of patients with endoxifen levels ≥ 16 nM using TDM. TDM is a safe strategy that offers the possibility of nearly halving the number of patients with endoxifen levels < 16 nM." @default.
• W3213528083 created "2021-11-22" @default.
• W3213528083 creator A5011887695 @default.
• W3213528083 creator A5019354298 @default.
• W3213528083 creator A5034599698 @default.
• W3213528083 creator A5044081315 @default.
• W3213528083 creator A5044911951 @default.
• W3213528083 creator A5045236213 @default.
• W3213528083 creator A5045797877 @default.
• W3213528083 creator A5047240860 @default.
• W3213528083 creator A5063356309 @default.
• W3213528083 creator A5064453966 @default.
• W3213528083 creator A5065885053 @default.
• W3213528083 creator A5070412633 @default.
• W3213528083 creator A5074174053 @default.
• W3213528083 creator A5075063332 @default.
• W3213528083 date "2021-11-17" @default.
• W3213528083 modified "2023-10-18" @default.
• W3213528083 title "Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer" @default.
• W3213528083 cites W1562190372 @default.
• W3213528083 cites W1836143067 @default.
• W3213528083 cites W1961026612 @default.
• W3213528083 cites W1966242613 @default.
• W3213528083 cites W1978470279 @default.
• W3213528083 cites W1986685858 @default.
• W3213528083 cites W1987126382 @default.
• W3213528083 cites W1987753117 @default.
• W3213528083 cites W2003726111 @default.
• W3213528083 cites W2004192017 @default.
• W3213528083 cites W2019766111 @default.
• W3213528083 cites W2035025788 @default.
• W3213528083 cites W2042168497 @default.
• W3213528083 cites W2044702943 @default.
• W3213528083 cites W2051318944 @default.
• W3213528083 cites W2069469265 @default.
• W3213528083 cites W2076734790 @default.
• W3213528083 cites W2076741971 @default.
• W3213528083 cites W2079689268 @default.
• W3213528083 cites W2104708747 @default.
• W3213528083 cites W2111738175 @default.
• W3213528083 cites W2118728607 @default.
• W3213528083 cites W2120384798 @default.
• W3213528083 cites W2122090386 @default.
• W3213528083 cites W2133468550 @default.
• W3213528083 cites W2135502243 @default.
• W3213528083 cites W2146913888 @default.
• W3213528083 cites W2147099166 @default.
• W3213528083 cites W2154067964 @default.
• W3213528083 cites W2155445734 @default.
• W3213528083 cites W2156455256 @default.
• W3213528083 cites W2261996569 @default.
• W3213528083 cites W2321112275 @default.
• W3213528083 cites W2407393655 @default.
• W3213528083 cites W2565952300 @default.
• W3213528083 cites W2618021260 @default.
• W3213528083 cites W2739614594 @default.
• W3213528083 cites W2792046032 @default.
• W3213528083 cites W2888043301 @default.
• W3213528083 cites W2904991649 @default.
• W3213528083 cites W2914126669 @default.
• W3213528083 cites W2924741552 @default.
• W3213528083 cites W2940687146 @default.
• W3213528083 cites W2950502611 @default.
• W3213528083 cites W2950922114 @default.
• W3213528083 cites W2951030580 @default.
• W3213528083 cites W2952250550 @default.
• W3213528083 cites W2952645223 @default.
• W3213528083 cites W2971583637 @default.
• W3213528083 cites W2995224844 @default.
• W3213528083 cites W2996737683 @default.
• W3213528083 cites W3014976138 @default.
• W3213528083 cites W3036119574 @default.
• W3213528083 cites W3036415919 @default.
• W3213528083 cites W3101630206 @default.
• W3213528083 cites W3123387100 @default.
• W3213528083 cites W3131226910 @default.
• W3213528083 cites W3217325936 @default.
• W3213528083 cites W4376849581 @default.
• W3213528083 doi "https://doi.org/10.1007/s40262-021-01077-z" @default.
• W3213528083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34786650" @default.
• W3213528083 hasPublicationYear "2021" @default.
• W3213528083 type Work @default.
• W3213528083 sameAs 3213528083 @default.
• W3213528083 citedByCount "13" @default.
• W3213528083 countsByYear W32135280832022 @default.
• W3213528083 countsByYear W32135280832023 @default.
• W3213528083 crossrefType "journal-article" @default.
• W3213528083 hasAuthorship W3213528083A5011887695 @default.
• W3213528083 hasAuthorship W3213528083A5019354298 @default.
• W3213528083 hasAuthorship W3213528083A5034599698 @default.
• W3213528083 hasAuthorship W3213528083A5044081315 @default.
• W3213528083 hasAuthorship W3213528083A5044911951 @default.
• W3213528083 hasAuthorship W3213528083A5045236213 @default.
• W3213528083 hasAuthorship W3213528083A5045797877 @default.
• W3213528083 hasAuthorship W3213528083A5047240860 @default.
• W3213528083 hasAuthorship W3213528083A5063356309 @default.
• W3213528083 hasAuthorship W3213528083A5064453966 @default.
• W3213528083 hasAuthorship W3213528083A5065885053 @default.

• next